Cargando…
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Despite treatment with statins, patients with elevated low-density lipoprotein cholesterol (LDL-C) and triglycerides remain at increased risk for adverse cardiovascular events. Consequently, novel pharmaceutical drugs have been developed to control and modify the composition of blood lipids to ultim...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462544/ https://www.ncbi.nlm.nih.gov/pubmed/37486464 http://dx.doi.org/10.1007/s40256-023-00594-5 |